DSM expands process R&D offering in deal with c-LEcta
DSM Pharmaceutical Products has expanded its portfolio of alcohol dehydrogenases in a licensing deal with German custom enzyme developer c-LEcta.
DSM Pharmaceutical Products has expanded its portfolio of alcohol dehydrogenases in a licensing deal with German custom enzyme developer c-LEcta.
Bayer HealthCare is investing €35m ($47m) in a new centre for the biotechnological production of ‘innovative’ pharmaceuticals to be used in clinical trials.
PharmaNet has launched its Initiator data capture and PKS analysis platforms in a bid to speed up data acquisition and processing of Phase I trial reports.
INC Research has shifted its headquarters to new and larger offices as part of the firm’s wider plan to ramp up its clinical trials outsourcing operations in Research Triangle, US.
Generex has been awarded a new patent for its buccal drug delivery platform technologies.
PRA International has opened a new Phase I unit in Prague in the Czech Republic, continuing its recent expansion programme.
US CRO Dedicated Phase I (DPI) says plan to set up first in human (FIH) unit at Phoenix hospital reflects growing drug industry demand for studies in this setting.
The US FDA said it has found more problems at J&J’s manufacturing facility in Fort Washington, Pennsylvania.